Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 5
Original Research
A replication-incompetent CD154/40L recombinant vaccinia virus induces direct and macrophage-mediated antitumor effects in vitro and in vivo
, 
, , , , , , , & show all
Alvaro BrittoliDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italyhttps://orcid.org/0000-0002-0459-4198View further author information
https://orcid.org/0000-0002-0459-4198View further author information, , Maurizio PinamontiUnit of Pathology, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italyhttps://orcid.org/0000-0002-9277-9378View further author information
https://orcid.org/0000-0002-9277-9378View further author information, , , , , & show allRelated Research Data
A Breakthrough: Macrophage-Directed Cancer Immunotherapy
Source:
American Association for Cancer Research (AACR)
Maturation-dependent expression of AIM2 in human B-cells
Source:
Public Library of Science (PLoS)
Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA
Source:
The American Association of Immunologists
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging.
Source:
Springer Science and Business Media LLC
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer.
Source:
Springer Science and Business Media LLC
Tumour-educated macrophages promote tumour progression and metastasis
Source:
Springer Science and Business Media LLC
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
Source:
American Society of Hematology
The immune contexture in human tumours: impact on clinical outcome
Source:
Springer Science and Business Media LLC
Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: a Novel Method to Handle the Interval Censoring Caused by Measurement of Smaller Tumors.
Source:
Springer Science and Business Media LLC
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Source:
Springer Science and Business Media LLC
Tumor-associated macrophages: functional diversity, clinical significance, and open questions
Source:
Springer Science and Business Media LLC
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
Source:
Elsevier BV
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Source:
Elsevier BV
A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell
Source:
Springer Science and Business Media LLC
GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Source:
American Association for Cancer Research (AACR)
Role of Crosslinking for Agonistic CD40 Monoclonal Antibodies as Immune Therapy of Cancer
Source:
American Association for Cancer Research (AACR)
CD40-targeted cancer vaccines
Source:
Wiley
Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation.
Source:
Elsevier BV
Cross-presentation, dendritic cells, tolerance and immunity.
Source:
Annual Reviews
Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
Source:
Springer Science and Business Media LLC
A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
Source:
American Association for Cancer Research (AACR)
Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control
Source:
Springer Berlin Heidelberg
Tumor-associated macrophages: from mechanisms to therapy.
Source:
Elsevier BV
Immunomodulation
Source:
Wiley
Targeting tumor-infiltrating macrophages to combat cancer
Source:
Future Medicine Ltd
Macrophage Diversity Enhances Tumor Progression and Metastasis
Source:
Elsevier BV
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
Source:
Wiley
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Source:
Elsevier BV
CD40 immunotherapy for pancreatic cancer
Source:
Springer Science and Business Media LLC
Macrophage plasticity and polarization: in vivo veritas
Source:
American Society for Clinical Investigation
Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer.
Source:
American Association for Cancer Research (AACR)
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
Source:
Proceedings of the National Academy of Sciences
Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Source:
Mary Ann Liebert Inc
Linking provided by
